Flumazenil NDC 51662-1579

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1579Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1579Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1579-3	51662157903	10 POUCH in 1 CASE (51662-1579-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1579-2) / 5 mL in 1 VIAL, MULTI-DOSE (51662-1579-1)Marketed from Jun 28, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Flumazenil
Generic name (nonproprietary): flumazenil
Active ingredients: Flumazenil — .1 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076955
Marketing start: Jun 28, 2021
Listing expires: Dec 31, 2027
Identifiers: Product ID 51662-1579_558ff617-4bcb-02b1-e063-6294a90a2517SPL ID 558ff617-4bcb-02b1-e063-6294a90a2517SPL set ID c5da455f-3213-ab11-e053-2995a90a54eeRxCUI 204508UNII 40P7XK9392UPC 0363323424053
Pharmacologic class: Benzodiazepine Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662157903 followed by a unit qualifier and the quantity

Package 51662-1579-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 1, 2026.

Indications (excerpt from the label)

INDICATIONS & USAGE Adult Patients Flumazenil Injection, USP is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. Pediatric Patients (aged 1 to 17) Flumazenil Injection, USP is indicated for the reversal of conscious sedation induced with benzodiazepines (see PRECAUTIONS, PEDIATRIC USE ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076955

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076955
Product	Strength	Form · route	Labeler	Product NDC
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7375
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	63323-424
Flumazenil	Flumazenil .1 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1699